Rational drug design : (Record no. 67088)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01743nam a22001937a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 210810b1999 ||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780190941925 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.19 PAR-A |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Parrill, Abby L. |
245 ## - TITLE STATEMENT | |
Title | Rational drug design : |
Remainder of title | novel methodology and practical applications / |
Statement of responsibility, etc. | Abby L. Parrill and M. Rami Reddy |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc. | Las Vegas |
Name of publisher, distributor, etc. | American Chemical Society |
Date of publication, distribution, etc. | 1999 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 374 p. |
365 ## - TRADE PRICE | |
Price type code | INR |
Price amount | 2995.00. |
500 ## - GENERAL NOTE | |
General note | Overview of Rational Drug Design, Conformational and Energetic Aspects of Receptor-Ligand Recognition, New Free Energy Calculation Methods for Structure-Based Drug Design and Prediction of Protein Stability, Binding Evaluation Using the Finite Difference Solution to the Linearized Poisson-Boltzmann Equation and salvation Entropy Correction, SmoG: A Ligand Design Method Based on Knowledge-Based Parametrization of a Solvent Reorganization Model, The Evaluation of Multi-Body Dynamics for Studying Ligand-Protein Interactions: Using MBO (N)D to Probe the Unbinding Pathways of Cbz-Val-Phe-Phe-Val-Cbz from the Active Site of HIV-1 Phase, Calculation of Relative Hydration Free Energy Differences for Heteroaromatic Compounds: Use in the Design of AMP Deaminase Inhibitors, New Tools for Rational Drug Design, Rational Approaches to Inhibition of Human Osteoclast Cathepsin K and Treatment of Osteoporosis, Building a Hypothesis for Nucleotide Transport Inhibitors Unified Pharmacophoric Model for Cannabinoids and Aminoalkylindoles Derived from Molecular Superimposition of CB Cannabinoid Receptor Agonists CP55244 and WIN55212-2. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Combinatorial chemistry |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs--Design |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drugs--Structure-activity relationships |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Reddy, M. Rami |
952 ## - LOCATION AND ITEM INFORMATION (KOHA) | |
Withdrawn status |
Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dewey Decimal Classification | 610 | BITS Pilani Hyderabad | BITS Pilani Hyderabad | General Stack (For lending) | 10/08/2021 | 615.19 PAR-A | 42633 | 13/07/2024 | 10/08/2021 | Books |